Center for Scientific Review will hold closed meetings to review research grant applications and provide advice on scientific matters to the National Institutes of Health.
Center for Scientific Review amended notice of meeting for the National Institutes of Health scientific review group; meeting details and date available in Federal Register notice.
The National Cancer Institute offers licensing of the A1847 human ovarian carcinoma cell line, a BRCA1-deficient model for researchers studying cell cycle regulation, tumor suppression, and DNA damage repair drugs.
The EPA will transfer pesticide product data and claimed confidential business information to the Department of Justice and litigation parties under FIFRA and FFDCA disclosure rules.
Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.
NIH submits its Extramural Harassment Web Form for OMB review under the Paperwork Reduction Act, with a 30-day public comment period.
EPA releases draft risk evaluation of flame retardant TBBPA under TSCA and requests public comment on whether the chemical presents unreasonable health or environmental risks under current use conditions.
National Institute of Diabetes and Digestive and Kidney Diseases announces an amended meeting notice for its advisory council to discuss research priorities and funding initiatives affecting small biotech and life-sciences firms.
Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.
National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
